While countries are seeking a Covid-19 vaccine to prevent the spread of coronavirus, pharmaceutical giant Pfizer Inc. said Friday that it reached a multi-year agreement with Gilead Sciences, Inc. to manufacture and obtain Gilead’s resivir, a remedy that has shown promise. in the opposite fight against the fatal virus.
Pfizer, working with German pharmaceutical company BioNTech on a possible vaccine opposed to Covid-19, said in a press release that Pfizer’s agreement was part of a broader effort to develop the source of an experimental remedy for Covid-19.
Under the agreement, Pfizer will supply contract production to Pfizer’s plant in McPherson, Kansas, to manufacture and obtain disdesivir for Gilead; the press release did not mention the terms of the agreement or the main points of origin of the production.
As Covid-19 cases spread around the world and no country is more affected than the United States, the search for a vaccine and a remedy has become the holy grail among pharmaceutical actors, large and small, with much of the studies funded throughout the United States. States. State government.
The Milken Institute’s Covid-19 tracker lists 202 recently developed vaccines, 24 of which are under test.
Meanwhile, doctors have been seeking effective treatment, and Preaspectnt Trump proceeded to promote hydroxychloroquine, a drug for arthritis and malaria that studies have shown is useless in treating Covid-19 and that can cause serious side effects.
Remdesivir obtained emergency approval from the Food and Drug Administration as a remedy for patients with critically ill Covid-19, but did not obtain final formal approval; The drug showed positive effects in a large-scale U.S. government trial, the company said in April.
“Pfizer’s agreement with Gilead is an example of members of the innovation ecosystem who combine to provide medical solutions. Together, we are tougher than alone.”
160,111: This is the number of deaths by Covid-19 in the United States since the onset of the pandemic, through the largest number of all countries.
Billions of dollars in sales are at stake, as pharmaceutical corporations around the global fight to locate remedies and vaccines for Covid-19, the coronavirus disease that has caused 19 million cases worldwide, totaling only about five million in the United States and leading to 71 five, five five five deaths worldwide. Logistical considerations abound about how the world can boost production fairly quickly, and there are moral doubts about who deserves to obtain a vaccination and remedy policy first. Pfizer has production facilities in the United States and the company said it uses 3 in its Covid-19 vaccine program: St. Louis, Missouri (raw curtain production), Andover, Massachusetts (pharmaceutical substance) and Kalamazoo (formulation, filling and finishing).
In July, R-Fla. Senator Marco Rubio complained on social media about the unavailability of revolutionary covid-19 drug reemployment, accusing the fed of a “bad disconnect.”
Pfizer announces with Gilead the manufacture of re-1ivir for COVID-19 (Pfizer)
Rubio complains about the rarity of the drug re-ivir Covid-19 (Forbes)
I’m a chi-town woman chasing news from Milwaukee to the west coast of Texas. Do you have a wonderful story to share? I mean listen.